array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Regeneron Pharmaceuticals Inc" ["slug"]=> string(38) "c469a-us-regeneron-pharmaceuticals-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77" ["description"]=> string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. " ["address_street"]=> string(25) "777 Old Saw Mill River Rd" ["address_place"]=> string(9) "Tarrytown" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1988-02-08" ["website_domain"]=> string(13) "regeneron.com" ["website_url"]=> string(25) "https://www.regeneron.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(10368) ["article_count"]=> int(2432) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(24) "Positive American market" ["snippet_en"]=> string(52) "Analysts rule out a first interest rate cut in June." ["url"]=> string(76) "https://www.teleborsa.it/News/2024/04/11/mercato-americano-positivo-215.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ffa1e261-4820-40fe-b63f-f6d97e813802" ["source"]=> string(12) "teleborsa.it" ["publication_date"]=> string(10) "2024-04-11" ["categories"]=> array(1) { [0]=> string(15) "Market Movement" } } [1]=> array(7) { ["title_en"]=> string(108) "Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following Fundamentals?" ["snippet_en"]=> string(120) "Regeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by a significant 20..." ["url"]=> string(87) "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-nasdaq-regn-130019594.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4f3da250-a78a-44f9-827d-452c8f1cf48d" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-02-29" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" } } [2]=> array(7) { ["title_en"]=> string(86) "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day" ["snippet_en"]=> string(157) "Shares of Regeneron Pharmaceuticals Inc. slipped 0.69% to $940.48 Tuesday, on what proved to be an all-around dismal trading session for the stock market,..." ["url"]=> string(145) "https://www.marketwatch.com/data-news/regeneron-pharmaceuticals-inc-stock-outperforms-competitors-despite-losses-on-the-day-10a2f390-5ce06124e555" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ce0eb208-fffe-4f22-868f-2bef6909c643" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2024-02-13" ["categories"]=> array(4) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" [3]=> string(24) "Quarterly/Annual Figures" } } [3]=> array(7) { ["title_en"]=> string(32) "Health Care Roundup: Market Talk" ["snippet_en"]=> string(134) "Find insight on Helen of Troy, Sanofi, Regeneron Pharmaceuticals and more in the latest Market Talks covering the Health Care sector." ["url"]=> string(74) "https://www.wsj.com/health/pharma/health-care-roundup-market-talk-9be34cf2" ["image_url"]=> string(78) "https://images.businessradar.com/articles/677d9872-b550-40fd-8cd7-8862120f1ed8" ["source"]=> string(7) "wsj.com" ["publication_date"]=> string(10) "2024-01-08" ["categories"]=> array(5) { [0]=> string(24) "Access and affordability" [1]=> string(11) "Competition" [2]=> string(15) "Market Movement" [3]=> string(16) "Customer Welfare" [4]=> string(24) "Employee Health & Safety" } } [4]=> array(7) { ["title_en"]=> string(87) "Regeneron Pharmaceuticals, Inc. Share Price Target '$942.05', now 2.7% Upside Potential" ["snippet_en"]=> string(87) "Regeneron Pharmaceuticals, Inc. Share Price Target '$942.05', now 2.7% Upside Potential" ["url"]=> string(131) "https://www.directorstalkinterviews.com/regeneron-pharmaceuticals-inc.share-price-target-942.05-now-2.7-upside-potential/4121137565" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ce3c6fbf-761d-4c8e-9b83-763bef93daf1" ["source"]=> string(27) "directorstalkinterviews.com" ["publication_date"]=> string(10) "2024-01-05" ["categories"]=> array(3) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" } } [5]=> array(7) { ["title_en"]=> string(56) "Buy These 4 Low-Beta Stocks to Counter Market Volatility" ["snippet_en"]=> string(191) "It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Otter Tail (OTTR), Regeneron (REGN), Kanzhun Limited (BZ) and Stride (LRN) are well-poised to gain." ["url"]=> string(67) "https://finance.yahoo.com/news/buy-4-low-beta-stocks-125000635.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/33ce902f-6be0-466e-b0ca-374be9f6b577" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-01-03" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" } } [6]=> array(7) { ["title_en"]=> string(42) "TradeVille Analysis - Biotechnology and AI" ["snippet_en"]=> string(201) "2023 was a difficult year for the biotechnology sector globally, but analysts say that the market seems to have reached a minimum, and 2024 is expected to be a turning point for companies in the field." ["url"]=> string(68) "https://www.bursa.ro/analiza-tradeville-biotehnologia-si-ai-48265157" ["image_url"]=> string(78) "https://images.businessradar.com/articles/dc704a2c-7cd8-4392-b7d4-d236bf489082" ["source"]=> string(8) "bursa.ro" ["publication_date"]=> string(10) "2023-12-28" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(14) "Product Launch" [2]=> string(15) "Market Movement" } } [7]=> array(7) { ["title_en"]=> string(100) "Global Retirement Partners LLC Purchases 100 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)" ["snippet_en"]=> string(223) "Global Retirement Partners LLC increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 67.1% during the 3rd quarter, according to the company in its most recent filing with the SEC." ["url"]=> string(140) "https://www.defenseworld.net/2023/12/27/global-retirement-partners-llc-purchases-100-shares-of-regeneron-pharmaceuticals-inc-nasdaqregn.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ea88b4c0-36a5-4473-b0a3-9af0e5140973" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-12-27" ["categories"]=> array(11) { [0]=> string(11) "Acquisition" [1]=> string(18) "General Investment" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(11) "Regulations" [4]=> string(16) "Share Repurchase" [5]=> string(12) "Stock Market" [6]=> string(15) "Market Movement" [7]=> string(24) "Quarterly/Annual Figures" [8]=> string(24) "Stock Research & Ratings" [9]=> string(14) "Issuing Shares" [10]=> string(13) "Credit Rating" } } [8]=> array(7) { ["title_en"]=> string(82) "Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price Is Out Of Tune With Earnings" ["snippet_en"]=> string(116) "With a price-to-earnings (or "P/E") ratio of 22.9x Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) may be sending..." ["url"]=> string(87) "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-nasdaq-regn-130106668.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a5c2673e-29e5-4263-bca0-a36a50b213b1" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-12-18" ["categories"]=> array(4) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" [3]=> string(24) "Quarterly/Annual Figures" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(197) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(193) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(152) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(99) } [4]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(95) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(83) } [6]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(70) } [7]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(61) } [8]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(51) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(50) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(46) } [11]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(44) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(35) } [14]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(34) } [15]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(33) } [16]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(33) } [17]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(32) } [18]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(31) } [19]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(31) } [20]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(31) } [21]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(29) } [22]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(29) } [23]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(23) } [28]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(20) } [29]=> array(2) { ["name"]=> string(8) "Politics" ["count"]=> int(20) } } } c469a-us-regeneron-pharmaceuticals-inc